» Authors » Josep M Hilari

Josep M Hilari

Explore the profile of Josep M Hilari including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 34
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tejera-Vaquerizo A, Ribero S, Puig S, Boada A, Paradela S, Moreno-Ramirez D, et al.
Cancer Med . 2019 Jun; 8(9):4235-4244. PMID: 31215168
Mitotic rate is no longer considered a staging criterion for thin melanoma in the 8th edition of the American Joint Committee on Cancer Staging Manual. The aim of this observational...
2.
Hilari J, Mangas C, Xi L, Paradelo C, Ferrandiz C, Hughes S, et al.
Ann Surg Oncol . 2008 Nov; 16(1):177-85. PMID: 18982394
The aim of this study was to evaluate the prognostic potential of quantitative reverse-transcription, polymerase chain reaction (qRT-PCR) in melanoma patients with pathologically negative sentinel lymph nodes (SLN). Our study...
3.
Vela E, Hilari J, Delclaux M, Fernandez-Bellon H, Isamat M
BMC Res Notes . 2008 Aug; 1:57. PMID: 18710510
Background: The human CD44 gene contains 10 variable exons (v1 to v10) that can be alternatively spliced to generate hundreds of different CD44 protein isoforms. Human CD44 variable exon v3...
4.
Vela E, Hilari J, Roca X, Munoz-Marmol A, Ariza A, Isamat M
RNA . 2007 Oct; 13(12):2312-23. PMID: 17940137
The human CD44 gene encodes multiple isoforms of a transmembrane protein that differ in their extracellular domains as a result of alternative splicing of its variable exons. Expression of CD44...
5.
Mangas C, Hilari J, Paradelo C, Rex J, Fernandez-Figueras M, Fraile M, et al.
Ann Surg Oncol . 2006 Jun; 13(7):910-8. PMID: 16788751
Background: We performed this study to evaluate the clinical effect of microscopic and submicroscopic metastases in sentinel lymph nodes (SLNs) from patients with early-stage melanoma. Methods: Patients with confirmed cutaneous...